Dipyridyl alkaloid, preparation method therefor and use thereof
US-2019322638-A1 · Oct 24, 2019 · US
US10696995B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10696995-B2 |
| Application number | US-201615559193-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 17, 2016 |
| Priority date | Mar 19, 2015 |
| Publication date | Jun 30, 2020 |
| Grant date | Jun 30, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for producing a glycosylated synthon or a monomer. Said method includes at least one step of placing at least one glycan-saccharase in the presence of at least one hydroxylated synthon and at least one saccharose. The invention also relates to a method for producing a glyco(co)polymer, including polymerizing at least two monomers separately obtained from the enzymatic glycosylation method according to the invention, and to a method for producing a glyco(co)polymer, preferably a block glyco(co)polymer, including coupling at least two monomers separately obtained from the enzymatic glycosylation method according to the invention.
Opening claim text (preview).
The invention claimed is: 1. A process for manufacturing a glycosylated synthon, or monomer, comprising at least one step of placing at least one glycan-saccharase in contact with at least one hydroxylated synthon and at least one sucrose, in which: (A) said hydroxylated synthon is chosen from the group constituted of: (i) (meth)acrylate/(meth)acrylamide synthons of formula (I): in which: R 1 represents a hydrogen atom or a C 1 -C 3 alkyl; R 2 represents a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) n , with n being an integer between 1 and 10; and X 1 represents —(O)—, —(NH)—, —(S)— or —(NR′ 2 (OH))—, with R′ 2 representing a C 1 -C 20 alkylene group; or a group —(C 2 H 4 O) m —, with m being an integer between 1 and 10; (ii) styrene-based synthons of formula (II): in which R 3 represents a covalent bond; a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) n , with n being an integer between 1 and 10; (iii) N-carboxyanhydride (NCA) synthons of formula (III): in which R 4 represents a covalent bond; a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) n , with n being an integer between 1 and 10; (iv) lactone/lactam/thiolactone synthons of formula (IV): in which: R 5 represents a covalent bond; a C 1 -C 20 alkylene group; or a group (C 2 H 4 O) m , with m being an integer between 1 and 10; n represents an integer between 1 and 20; X 2 represents —(O)—, —(NH)— or —(S)—; and R 6 represents a hydrogen or a C 1 -C 20 alkyl group; (v) synthons of formula (V): in which R 7 represents a C 1 -C 20 alkylene group; and (vi) synthons of formula (VI): in which R 8 represents a C 1 -C 20 alkylene group; and (B) said glycan-saccharase is selected from the group consisting of a sequence having at least 80% identity with SEQ ID NO: 1, a sequence having at least 80% identity with SEQ ID NO: 1 mutated once at any one of the positions R226, I228, F229, A289, F290, I330, V331, D394 and R446; a sequence having at least 80% identity with SEQ ID NO: 11; a sequence having at least 80% identity with SEQ ID NO: 12; a sequence having at least 80% identity with SEQ ID NO: 13; a sequence having at least 80% identity with SEQ ID NO: 14; a sequence having at least 80% identity with SEQ ID NO: 15; a sequence having at least 80% identity with SEQ ID NO: 16; a sequence having at least 80% identity with SEQ ID NO: 17; and a sequence having at least 80% identity with SEQ ID NO: 18. 2. The process as claimed in claim 1 , in which the sequence having at least 80% identity with SEQ ID NO: 1 mutated once at any one of the positions R226, I228, F229, A289, F290, I330, V331, D394 and R446 is chosen from: a sequence having at least 80% identity with SEQ ID NO: 2, said sequence having an amino acid X 1 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 3, said sequence having an amino acid X 2 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 4, said sequence having an amino acid X 3 representing an amino acid chosen from the group constituted of A, C, D, E, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 5, said sequence having an amino acid X 4 representing an amino acid chosen from the group constituted of C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 6, said sequence having an amino acid X 5 representing an amino acid chosen from the group constituted of A, C, D, E, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 7, said sequence having an amino acid X 6 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, K, L, M, N, P, Q, R, S, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 8, said sequence having an amino acid X 7 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, 5, T, W and Y; a sequence having at least 80% identity with SEQ ID NO: 9, said sequence having an amino acid X 8 representing an amino acid chosen from the group constituted of A, C, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y; and a sequence having at least 80% identity with SEQ ID NO: 10, said sequence having an amino acid X 9 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V, W and Y. 3. The process as claimed in claim 1 , in which the sequence having at least 80% identity with SEQ ID NO: 1 mutated once at any one of the positions R226, I228, F229, A289, F290, I330, V331, D394 and R446 is chosen from: a sequence having at least 80% identity with SEQ ID NO: 2, said sequence having an amino acid X 1 representing an amino acid chosen from the group constituted of C, H, K, M, N, Q, S, T and V; a sequence having at least 80% identity with SEQ ID NO: 3, said sequence having an amino acid X 2 representing an amino acid chosen from the group constituted of H, L, T, V, W and Y; a sequence having at least 80% identity with SEQ ID NO: 4, said sequence having an amino acid X 3 representing an amino acid chosen from the group constituted of C, D, E, G, H, I, K, M, N, P, Q, V, W and Y; a sequence having at least 80% identity with the sequence SEQ ID NO: 5, said sequence having an amino acid X 4 representing an amino acid chosen from the group constituted of C, D, E, F, M, N, P, Q, S, T, V and W; a sequence having at least 80% identity with the sequence SEQ ID NO: 6, said sequence having an amino acid X 5 representing an amino acid chosen from the group constituted of A, C, D, E, G, H, I, K, L, M, P, Q, S, T, V and W; a sequence having at least 80% identity with the sequence SEQ ID NO: 7, said sequence having an amino acid X 6 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, K, L, M, N, Q, S, V and Y; a sequence having at least 80% identity with SEQ ID NO: 8, said sequence having an amino acid X 7 representing an amino acid chosen from the group constituted of A, C, D, E, F, G, H, I, K, L, N, Q, R, S, T, W and Y; a sequence having at least 80% identity with SEQ ID NO: 9, said sequence having an amino acid X 8 representing an amino acid chosen from the group constituted of A, E, F, G, H, I, K and L; a sequence having at least 80% identity with SEQ ID NO: 10, said sequence having an amino acid X 9 representing an amino acid chosen from the group constituted of A, C, G, K, L, M, N, and S. 4. The process as claimed in claim 1 , in which the hydroxylated synthon is chosen from the group consisting of 2-(hydroxy)ethyl methacrylate (HEMA), N-(hydroxy)methylacrylamide (NHAM), N-(hydroxy)ethylacrylamide (HEAA), 4-vinylphenol (VP), 4-vinylbenzyl alcohol (VBA), 4-(hydroxy)methyloxazolidine-2,5-dione (HMNCA), a-(hydroxy)methylcapr
having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin · CPC title
Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)} · CPC title
acting on glycosyl compounds (3.2) · CPC title
containing no aromatic rings in the alcohol moiety · CPC title
containing oxygen in addition to the carbonamido oxygen {, e.g. N-methylolacrylamide, N-acryloylmorpholine} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.